BackPMV Pharmaceuticals Overview
PMV Pharmaceuticals Inc

PMV Pharmaceuticals Target Price

See PMV Pharmaceuticals's analyst price targets ($5) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.29

Average Target Price

$5.00287.6% upside

1 analysts in the last 4 months

High: $5 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-13Oppenheimer$5287.6% upsideOpen
2024-11-08OppenheimerJeff Jones$6365.1% upsideOpen
2024-04-11JefferiesKambiz Yazdi$5287.6% upsideOpen
2022-11-17H.C. Wainwright$362690.7% upsideOpen
2022-06-09Oppenheimer$332458.1% upsideOpen
2022-05-24Goldman Sachs$251838% upsideOpen

PMV Pharmaceuticals (PMVP) FAQ

As of the most recent data, PMVP shows a target price of $5. Scroll down for historical charts and peer comparison views.

If PMV Pharmaceuticals moved to the average analyst target of $5, shares would be roughly 287.6% higher than $1.29. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of PMV Pharmaceuticals's earnings trajectory.

Besides this target price page, Stockcircle has PMV Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $5) with ownership activity and broader fundamentals.

PMV Pharmaceuticals's target price is $5; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.